# BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults

> **NCT02819297** · PHASE3 · COMPLETED · sponsor: **Braintree Laboratories** · enrollment: 1020 (actual)

## Conditions studied

- Constipation
- Chronic Idiopathic Constipation
- CIC

## Interventions

- **DRUG:** BLI400 Laxative
- **DRUG:** BLI400 Placebo

## Key facts

- **NCT ID:** NCT02819297
- **Lead sponsor:** Braintree Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-06
- **Primary completion:** 2017-06
- **Final completion:** 2017-06
- **Target enrollment:** 1020 (ACTUAL)
- **Last updated:** 2020-07-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02819297

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02819297, "BLI400-302: A Safety and Efficacy Evaluation of BLI400 Laxative in Constipated Adults". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT02819297. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*